PLAY PODCASTS
June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations

June JAAD: Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis Hidradenitis Suppurativa Foundations

AAD's Dialogues in Dermatology · AAD

June 1, 2022

Audio is streamed directly from the publisher (resources.aad.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Suiting Ao, MD and Wang Fang, MD interviewed by Steven Chen, MD, FAAD